{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T21:18:26Z","timestamp":1783372706223,"version":"3.54.6"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002999","name":"Ministerie van Volksgezondheid, Welzijn en Sport","doi-asserted-by":"publisher","award":["50-50110-98-020"],"award-info":[{"award-number":["50-50110-98-020"]}],"id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["62000015"],"award-info":[{"award-number":["62000015"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jamda.2019.05.010","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T08:17:13Z","timestamp":1562660233000},"page":"188-193.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Association of Benzodiazepine and Anticholinergic Drug Usage With Incident Dementia: A Prospective Cohort Study of Community-Dwelling Older Adults"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0972-8615","authenticated-orcid":false,"given":"Melanie","family":"Hafdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke P.","family":"Hoevenaar-Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathrien R.L.","family":"Beishuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric P.","family":"Moll van Charante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edo","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A.","family":"van Gool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2019.05.010_bib1","series-title":"Dementia; Fact sheet","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.jamda.2019.05.010_bib2","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1161\/01.STR.0000143318.70292.47","article-title":"Risk factors for vascular dementia and Alzheimer disease","volume":"35","author":"Gorelick","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jamda.2019.05.010_bib3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.euroneuro.2012.05.004","article-title":"Chronic use of benzodiazepines and latent cognitive decline in the elderly: Results from the Three-city study","volume":"23","author":"Mura","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jamda.2019.05.010_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S0033291704003897","article-title":"Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies","volume":"35","author":"Verdoux","year":"2005","journal-title":"Psychol Med"},{"key":"10.1016\/j.jamda.2019.05.010_bib5","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1532-5415.2011.03491.x","article-title":"Anticholinergic medication use and cognitive impairment in the older population: The medical research council cognitive function and ageing study","volume":"59","author":"Fox","year":"2011","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2019.05.010_bib6","doi-asserted-by":"crossref","first-page":"e0127836","DOI":"10.1371\/journal.pone.0127836","article-title":"Association between benzodiazepine use and dementia: A meta-analysis","volume":"10","author":"Zhong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jamda.2019.05.010_bib7","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/archinternmed.2009.229","article-title":"Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population","volume":"169","author":"Carri\u00e8re","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jamda.2019.05.010_bib8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jamda.2019.05.010_bib9","first-page":"225","article-title":"The cognitive impact of anticholinergics: A clinical review","volume":"4","author":"Campbell","year":"2009","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jamda.2019.05.010_bib10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/JGP.0b013e3181a65210","article-title":"The association between dementia and long-term use of benzodiazepine in the elderly: Nested case-control study using claims data","volume":"17","author":"Wu","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2019.05.010_bib11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1017\/S1041610204000420","article-title":"Prevalence and appropriateness of psychotropic drug use in old age: Results from the Berlin Aging Study (BASE)","volume":"16","author":"Linden","year":"2004","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2019.05.010_bib12","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1007\/s00406-010-0156-4","article-title":"Anticholinergic drug use and risk for dementia: Target for dementia prevention","volume":"260","author":"Jessen","year":"2010","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.jamda.2019.05.010_bib13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/bmj.38740.439664.DE","article-title":"Nondegenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: Longitudinal cohort study","volume":"332","author":"Ancelin","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2019.05.010_bib14","doi-asserted-by":"crossref","first-page":"i90","DOI":"10.1136\/bmj.i90","article-title":"Benzodiazepine use and risk of incident dementia or cognitive decline: Prospective population-based study","volume":"352","author":"Gray","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2019.05.010_bib15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(16)30950-3","article-title":"Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): A cluster-randomised controlled trial","volume":"388","author":"Moll van Charante","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2019.05.010_bib16","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)","year":"2000"},{"key":"10.1016\/j.jamda.2019.05.010_bib17","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2019.05.010_bib18","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","article-title":"Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria","volume":"51","author":"Neary","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2019.05.010_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/JAD-2006-9S347","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop","volume":"9","author":"McKeith","year":"2006","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2019.05.010_bib20","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop","volume":"47","author":"McKeith","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2019.05.010_bib21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS-AIREN International Workshop","volume":"43","author":"Roman","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2019.05.010_bib22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","article-title":"Impact of anticholinergics on the aging brain: A review and practical application","volume":"4","author":"Boustani","year":"2008","journal-title":"Aging Health"},{"key":"10.1016\/j.jamda.2019.05.010_bib23","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s40264-015-0319-3","article-title":"Benzodiazepine use and risk of developing Alzheimer's disease or vascular dementia: A case-control analysis","volume":"38","author":"Imfeld","year":"2015","journal-title":"Drug Safety"},{"key":"10.1016\/j.jamda.2019.05.010_bib24","doi-asserted-by":"crossref","first-page":"e6231","DOI":"10.1136\/bmj.e6231","article-title":"Benzodiazepine use and risk of dementia: Prospective population based study","volume":"345","author":"Billioti de Gage","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2019.05.010_bib25","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer's disease: Case-control study","volume":"349","author":"Billioti de Gage","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2019.05.010_bib26","doi-asserted-by":"crossref","first-page":"k1315","DOI":"10.1136\/bmj.k1315","article-title":"Anticholinergic drugs and risk of dementia: Case-control study","volume":"361","author":"Richardson","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2019.05.010_bib27","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1176\/appi.ps.201500011","article-title":"Risk of dementia among elderly nursing home patients using paroxetine and other selective serotonin reuptake inhibitors","volume":"66","author":"Bali","year":"2015","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.jamda.2019.05.010_bib28","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1177\/1741826711422979","article-title":"Cardiovascular risk management in community-dwelling elderly: Opportunities for prevention","volume":"19","author":"Ligthart","year":"2012","journal-title":"Eur J Prev Cardiol"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861019304281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861019304281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:20:23Z","timestamp":1761506423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861019304281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1525861019304281"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2019.05.010","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Benzodiazepine and Anticholinergic Drug Usage With Incident Dementia: A Prospective Cohort Study of Community-Dwelling Older Adults","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2019.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}